TNFA   $5.2  48.15% Market Closed

TNF Pharmaceuticals, Inc.
Total Cash 13.07M
totalCashPerShare 5.512
EBITDA
Total Debt 25.80K
quickRatio 2.26
currentRatio 2.483
Total Revenue
debtToEquity 6.75
Revenue/Share
ROA -0.32434
ROE -2.97628
grossProfits
freeCashflow -2.49M
operatingCashflow -9.67M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue -9.46M
forwardPE
floatShares 2.17M
sharesOutstanding 2.37M
sharesShort 252.88K
sharesShortPriorMonth 252.46K
dateShortInterest
sharesPercentSharesOut 0.11%
heldPercentInsiders 0.06%
heldPercentInstitutions 0.40%
Short Ratio help_outline 5.39%
shortPercentOfFloat 0.14%
impliedSharesOutstanding
bookValue -0.02
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -23.35M
trailingEps -10.48%
forwardEps
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate 1Q 2018
institutionsCount 28
lastUpdated Nov. 2, 2024, 7:53 a.m.